Loading...

HLMA: Upward Pricing Revisions Will Underpin Confidence Despite Valuation Concerns

Published
24 Nov 24
Updated
25 Apr 26
Views
228
25 Apr
UK£44.92
AnalystConsensusTarget's Fair Value
UK£40.33
11.4% overvalued intrinsic discount
Loading
1Y
54.6%
7D
-4.3%

Author's Valuation

UK£40.3311.4% overvalued intrinsic discount

AnalystConsensusTarget Fair Value

Last Update 25 Apr 26

Fair value Increased 2.78%

HLMA: Higher Assumptions And Neutral Stance Will Support Premium Future P/E

Halma's analyst price target has been adjusted from £40.00 to £41.50. Analysts link this shift to updated assumptions for fair value, discount rate, revenue growth, profit margin and future P/E.

Analyst Commentary

JPMorgan's move to lift its Halma price target to 4,150 GBp from 4,000 GBp, while keeping a Neutral rating, gives you a mixed but useful read on how the stock is being viewed on valuation and execution.

Bullish Takeaways

  • Bullish analysts view the higher £41.50 target and JPMorgan's 4,150 GBp level as support for the idea that current assumptions on fair value can justify a slightly richer valuation, even without a ratings upgrade.
  • The updated work on discount rate and future P/E implies that some analysts see Halma as able to support a valuation that is not purely dependent on near term earnings, which can appeal to investors who are comfortable paying up for perceived quality.
  • Revisiting revenue growth and profit margin assumptions suggests confidence that the business model is resilient enough for analysts to underwrite a higher long term earnings power in their models.
  • The combination of a higher target and a Neutral stance can be read as a sign that Halma remains firmly on institutional radar screens, which may help liquidity and research coverage depth for existing and prospective shareholders.

Bearish Takeaways

  • JPMorgan's decision to keep a Neutral rating, despite lifting the target to 4,150 GBp, signals that some analysts still see limited near term upside at current levels relative to their fair value work.
  • The reliance on adjusted assumptions for revenue growth, margins and future P/E also highlights the risk that, if these inputs do not materialise as modeled, the revised £41.50 target could prove optimistic.
  • Maintaining a Neutral view alongside a higher target suggests lingering caution on execution or valuation headroom, which may temper expectations for a strong re rating purely on the back of this target move.
  • For more risk aware investors, the fact that rating and target are not aligned in a clearly bullish stance can be a reminder to focus closely on entry price and on how actual earnings and cash generation compare with the assumptions embedded in current valuations.

Valuation Changes

  • Fair Value: Model fair value has moved from £39.24 to £40.33, representing a small upward adjustment in the implied share valuation reference point.
  • Discount Rate: The discount rate has been nudged from 8.91% to 8.95%, reflecting a very modest change in the risk and return hurdle used in the valuation work.
  • Revenue Growth: Assumed annual revenue growth has shifted from 10.46% to 10.71%, indicating a slightly higher growth input in analyst models, all expressed in £ terms.
  • Net Profit Margin: Forecast profit margin has moved from 15.57% to 15.70%, reflecting a marginal change in expected earnings efficiency on £ revenue.
  • Future P/E: The assumed future P/E multiple has adjusted from 37.76x to 38.26x, representing a small move that raises the valuation multiple applied to projected earnings.
7 viewsusers have viewed this narrative update

Key Takeaways

  • Strong cash generation and balance sheet support significant R&D and acquisition investments, ensuring sustainable growth and increased future revenues and earnings.
  • Focus on niche markets and talent investment boosts high margins and long-term growth potential, enhancing future profit margins and earnings.
  • Geopolitical instability, currency impact, and reliance on M&A and niche markets may challenge Halma's revenue, profit margins, and financial flexibility.

Catalysts

About Halma
    Together its subsidiaries, provides technology solutions in the safety, health, and environmental markets in the United States, Mainland Europe, the United Kingdom, the Asia Pacific, Africa, the Middle East, and internationally.
What are the underlying business or industry changes driving this perspective?
  • Continued strong cash generation and a healthy balance sheet have enabled substantial investments in R&D and acquisitions, ensuring sustainable future growth, which is likely to drive up revenues and earnings.
  • Acquisitions and a robust M&A pipeline spanning all sectors are contributing to EBIT growth and are expected to enhance future profit margins and earnings growth.
  • Organic revenue growth supported by price increases and strong demand ensures maintained high gross margins and potentially improved earnings.
  • Investment in talent and collaborative culture across a diverse portfolio positions Halma for consistent growth, enhancing long-term earnings potential.
  • Focus on high-value niche markets with strong, long-term growth drivers supports high margins and returns on invested capital, suggesting an increase in future net margins and earnings.
Halma Earnings and Revenue Growth

Halma Future Earnings and Revenue Growth

Assumptions

How have these above catalysts been quantified?

  • Analysts are assuming Halma's revenue will grow by 10.7% annually over the next 3 years.
  • Analysts assume that profit margins will increase from 14.4% today to 15.7% in 3 years time.
  • Analysts expect earnings to reach £513.8 million (and earnings per share of £1.27) by about April 2029, up from £347.0 million today.
  • In order for the above numbers to justify the price target of the analysts, the company would need to trade at a PE ratio of 38.3x on those 2029 earnings, down from 48.2x today. This future PE is greater than the current PE for the GB Electronic industry at 18.4x.
  • Analysts expect the number of shares outstanding to remain consistent over the next 3 years.
  • To value all of this in today's terms, we will use a discount rate of 8.95%, as per the Simply Wall St company report.

Risks

What could happen that would invalidate this narrative?
  • The ongoing geopolitical and economic volatility, along with an adverse currency movement impacting revenue growth, presents a risk that could limit Halma's financial performance. This currency drag, specifically the strengthening of sterling, has been noted as a headwind (revenue impact).
  • The decline in the Healthcare sector, notably in eye health therapeutics due to delays in OEM product launches and destocking, offsets growth in other areas and could strain profit margins if not rectified promptly (net margin and revenue impact).
  • The strategy of continuous M&A could present risks, especially if integration challenges arise or if acquired companies underperform. Recently acquired businesses, despite contributing to growth, sometimes require additional investment, affecting short-term profitability (earnings impact).
  • The reliance on high-margin niche markets and regulated industries means any shifts in regulatory policies or changes in market conditions could impact revenue streams and the overall margin performance, particularly if robustness in sustainability diminishes (net margins and revenue impact).
  • While current cash generation and dividend growth are strong, any shift in interest rates or economic conditions affecting cash conversion rates could challenge Halma's financial flexibility and ability to sustain high reinvestment and acquisition activities (cash flow and earnings impact).

Valuation

How have all the factors above been brought together to estimate a fair value?

  • The analysts have a consensus price target of £40.33 for Halma based on their expectations of its future earnings growth, profit margins and other risk factors.
  • However, there is a degree of disagreement amongst analysts, with the most bullish reporting a price target of £49.3, and the most bearish reporting a price target of just £30.5.
  • In order for you to agree with the analysts, you'd need to believe that by 2029, revenues will be £3.3 billion, earnings will come to £513.8 million, and it would be trading on a PE ratio of 38.3x, assuming you use a discount rate of 8.9%.
  • Given the current share price of £44.28, the analyst price target of £40.33 is 9.8% lower. The relatively low difference between the current share price and the analyst consensus price target indicates that they believe on average, the company is fairly priced.
  • We always encourage you to reach your own conclusions though. So sense check these analyst numbers against your own assumptions and expectations based on your understanding of the business and what you believe is probable.

Have other thoughts on Halma?

Create your own narrative on this stock, and estimate its Fair Value using our Valuator tool.

Create Narrative

How well do narratives help inform your perspective?

Disclaimer

AnalystConsensusTarget is a tool utilizing a Large Language Model (LLM) that ingests data on consensus price targets, forecasted revenue and earnings figures, as well as the transcripts of earnings calls to produce qualitative analysis. The narratives produced by AnalystConsensusTarget are general in nature and are based solely on analyst data and publicly-available material published by the respective companies. These scenarios are not indicative of the company's future performance and are exploratory in nature. Simply Wall St has no position in the company(s) mentioned. Simply Wall St may provide the securities issuer or related entities with website advertising services for a fee, on an arm's length basis. These relationships have no impact on the way we conduct our business, the content we host, or how our content is served to users. The price targets and estimates used are consensus data, and do not constitute a recommendation to buy or sell any stock, and they do not take account of your objectives, or your financial situation. Note that AnalystConsensusTarget's analysis may not factor in the latest price-sensitive company announcements or qualitative material.

Read more narratives